148 related articles for article (PubMed ID: 29946601)
1. Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones.
Salina EG; Huszár S; Zemanová J; Keruchenko J; Riabova O; Kazakova E; Grigorov A; Azhikina T; Kaprelyants A; Mikušová K; Makarov V
Metallomics; 2018 Jul; 10(7):992-1002. PubMed ID: 29946601
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.
Shah S; Dalecki AG; Malalasekera AP; Crawford CL; Michalek SM; Kutsch O; Sun J; Bossmann SH; Wolschendorf F
Antimicrob Agents Chemother; 2016 Oct; 60(10):5765-76. PubMed ID: 27431227
[TBL] [Abstract][Full Text] [Related]
3. New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
Salina EG; Ryabova O; Vocat A; Nikonenko B; Cole ST; Makarov V
J Infect Chemother; 2017 Nov; 23(11):794-797. PubMed ID: 28527650
[TBL] [Abstract][Full Text] [Related]
4. Antitubercular activity of novel substituted 4,5-dihydro-1H-1-pyrazolylmethanethiones.
Ali MA; Yar MS
J Enzyme Inhib Med Chem; 2007 Apr; 22(2):183-9. PubMed ID: 17518345
[TBL] [Abstract][Full Text] [Related]
5. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal effect of pyridine-2-thiol 1-oxide sodium salt and its complex with iron against resistant clinical isolates of Mycobacterium tuberculosis.
Campos DL; Machado I; Ribeiro CM; Gambino D; Pavan FR
J Antibiot (Tokyo); 2020 Feb; 73(2):120-124. PubMed ID: 31619772
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
9. New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells.
Salina E; Ryabova O; Kaprelyants A; Makarov V
Antimicrob Agents Chemother; 2014; 58(1):55-60. PubMed ID: 24126578
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
[TBL] [Abstract][Full Text] [Related]
11. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
[TBL] [Abstract][Full Text] [Related]
12. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics.
Machado D; Azzali E; Couto I; Costantino G; Pieroni M; Viveiros M
Future Microbiol; 2018 Sep; 13():1383-1402. PubMed ID: 30259757
[TBL] [Abstract][Full Text] [Related]
15. Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
Barbosa AR; Caleffi-Ferracioli KR; Leite CQ; García-Ramos JC; Toledano-Magaña Y; Ruiz-Azuara L; Siqueira VL; Pavan FR; Cardoso RF
Chemotherapy; 2016; 61(5):249-55. PubMed ID: 26950478
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
[TBL] [Abstract][Full Text] [Related]
17. Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.
Speer A; Shrestha TB; Bossmann SH; Basaraba RJ; Harber GJ; Michalek SM; Niederweis M; Kutsch O; Wolschendorf F
Antimicrob Agents Chemother; 2013 Feb; 57(2):1089-91. PubMed ID: 23254420
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2.
Gezginci MH; Martin AR; Franzblau SG
J Med Chem; 2001 May; 44(10):1560-3. PubMed ID: 11334565
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, transformations and tuberculostatic activity of 1-(N-aroylthiocarbamoyl)imidiazolidine-2-thiones.
Saczewski F
Acta Pol Pharm; 1993; 50(4-5):341-4. PubMed ID: 8036919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
